Mefloquine

Y. Vivian Tsai, Pharm.D., Edina Avdic, Pharm.D.
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS

INDICATIONS

FDA

  • Malaria prophylaxis, in areas without mefloquine resistance[10]
  • Malaria treatment[11]
    • Treatment of mild–moderate malaria caused by susceptible P. falciparum and P. vivax.
      • Clinical data are insufficient for P. ovale and P. malariae.

NON-FDA INDICATIONS

  • CDC recommendations: Mefloquine only when preferred treatment options are not available or cannot be used.
    • Uncomplicated disease due to P. falciparum or an unknown species when preferred options cannot be used.
    • Severe malaria (non-FDA): If IV artesunate is not immediately available, mefloquine may be used only as interim oral therapy while obtaining IV artesunate, and only when artemether-lumefantrine, atovaquone-proguanil, and quinine cannot be used.
    • P. vivax or P. ovale, including chloroquine-resistant areas in Papua New Guinea/Indonesia

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.